Blog
RSS FeedPosted by Michael Wonder on 27 Jul 2016
AbbVie racks up three more indications for Humira
27 July 2016 - The TGA has approved three new indications for Abbvie's Humira (adalimumab). ...
Posted by Michael Wonder on 27 Jul 2016
TGA finally approves Latisse (bimatoprost)
27 July 2016 - The TGA has approved a new use for Allergan's bimatoprost. ...
Posted by Michael Wonder on 18 Jul 2016
TGA cost recovery implementation statement 2016-17
18 July 2016 - This Cost Recovery Implementation Statement provides information on how the TGA implements cost recovery activities associated with ...
Posted by Michael Wonder on 07 Jul 2016
TGA approves Prometrium (progesterone)
7 July 2016 - The TGA has approved Besins Healthcare's Prometrium (progesterone). ...
Posted by Michael Wonder on 07 Jul 2016
TGA approves Descovy (emtricitabine with tenofovir alafenamide fumarate)
7 July 2016 - The TGA has approved Gilead Sciences' new dual combination product for patients with HIV infection. ...
Posted by Michael Wonder on 05 Jul 2016
TGA publishes AusPAR for asfotase alfa (Strensiq)
5 July 2016 - The TGA has published an AusPAR for Alexion Pharmaceuticals' Strensiq. ...
Posted by Michael Wonder on 05 Jul 2016
TGA publishes AusPAR for emtricitabine with elvitegravir and cobicistat and tenofovir alafenamide fumarate (Genvoya)
5 July 2016 - The TGA has published an AusPAR for Gilead's Genvoya. ...
Posted by Michael Wonder on 01 Jul 2016
TGA fees and charges from 1 July 2016
1 July 2016 - The TGA has published a summary of fees and charges, which are in the Australian therapeutic goods ...
Posted by Michael Wonder on 29 Jun 2016
Prescription medicines: pre-submission pilot
29 June 2016 - The TGA is introducing pilot changes to the pre-submission phase of the prescription medicines registration process. ...
Posted by Michael Wonder on 28 Jun 2016
TGA publishes AusPAR for Proshaeos (alprostadil)
28 June 2016 - The TGA has published an AusPAR for Montrose Pharma's Proshaeos (alprostadil). ...
Posted by Michael Wonder on 20 Jun 2016
TGA approves new indication for Glypressin (terlipressin acetate)
20 June 2016 - The TGA has approved a new indication for Ferring Pharmaceuticals' Glypressin (terlipressin acetate). ...
Posted by Michael Wonder on 15 Jun 2016
Hepatitis C sufferers’ ire at activist-website ban
14 June 2016 - A website which raises awareness about a medical cure for hepatitis C could be hidden from Australians. ...
Posted by Michael Wonder on 09 Jun 2016
TGA publishes AusPAR for Nuvigil (armodafinil)
9 June 2016 - The TGA has published an AusPAR for Teva's Nuvigil (armodafinil). ...
Posted by Michael Wonder on 06 Jun 2016
TGA publishes 2 new AusPARs
6 June 2016 - The TGA has published AusPARs for talimogene laherparepvec (Imlygic) & naloxegol oxalate (Movantik). ...
Posted by Michael Wonder on 02 Jun 2016
TGA approves lesinurad (Zurampic)
2 June 2016 - The TGA has approved Astra Zeneca's lesinurad (Zurampic). ...